169 related articles for article (PubMed ID: 18639523)
1. SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
Nishida T; Yamada Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):382-7. PubMed ID: 18639523
[TBL] [Abstract][Full Text] [Related]
2. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
Nishida T; Yamada Y
Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
[TBL] [Abstract][Full Text] [Related]
3. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase.
Nishida T; Tanaka H; Yasuda H
Eur J Biochem; 2000 Nov; 267(21):6423-7. PubMed ID: 11029585
[TBL] [Abstract][Full Text] [Related]
4. The importin-alpha/nucleophosmin switch controls taspase1 protease function.
Bier C; Knauer SK; Docter D; Schneider G; Krämer OH; Stauber RH
Traffic; 2011 Jun; 12(6):703-14. PubMed ID: 21418451
[TBL] [Abstract][Full Text] [Related]
5. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
6. SUMO regulates the cytoplasmonuclear transport of its target protein Daxx.
Chen A; Wang PY; Yang YC; Huang YH; Yeh JJ; Chou YH; Cheng JT; Hong YR; Li SS
J Cell Biochem; 2006 Jul; 98(4):895-911. PubMed ID: 16475184
[TBL] [Abstract][Full Text] [Related]
7. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.
Kuo ML; den Besten W; Thomas MC; Sherr CJ
Cell Cycle; 2008 Nov; 7(21):3378-87. PubMed ID: 18948745
[TBL] [Abstract][Full Text] [Related]
8. Characterization of SENP7, a SUMO-2/3-specific isopeptidase.
Shen LN; Geoffroy MC; Jaffray EG; Hay RT
Biochem J; 2009 Jun; 421(2):223-30. PubMed ID: 19392659
[TBL] [Abstract][Full Text] [Related]
9. Differential expression patterns of SUMO proteins in HL-60 cancer cell lines support a role for sumoylation in the development of drug resistance.
Vigodner M; Weisburg JH; Shrivastava V; Marmor RA; Fathy J; Skop N
Cell Tissue Res; 2009 May; 336(2):277-86. PubMed ID: 19326147
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
11. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
Shih HM; Chang CC; Kuo HY; Lin DY
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
[TBL] [Abstract][Full Text] [Related]
12. The SUMO-specific protease SENP5 is required for cell division.
Di Bacco A; Ouyang J; Lee HY; Catic A; Ploegh H; Gill G
Mol Cell Biol; 2006 Jun; 26(12):4489-98. PubMed ID: 16738315
[TBL] [Abstract][Full Text] [Related]
13. SUMO-specific proteases: a twist in the tail.
Hay RT
Trends Cell Biol; 2007 Aug; 17(8):370-6. PubMed ID: 17768054
[TBL] [Abstract][Full Text] [Related]
14. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.
Kim YH; Sung KS; Lee SJ; Kim YO; Choi CY; Kim Y
FEBS Lett; 2005 Nov; 579(27):6272-8. PubMed ID: 16253240
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.
Mariano AR; Colombo E; Luzi L; Martinelli P; Volorio S; Bernard L; Meani N; Bergomas R; Alcalay M; Pelicci PG
Oncogene; 2006 Jul; 25(31):4376-80. PubMed ID: 16501600
[TBL] [Abstract][Full Text] [Related]
16. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
[TBL] [Abstract][Full Text] [Related]
17. Binding to small ubiquitin-like modifier and the nucleolar protein Csm1 regulates substrate specificity of the Ulp2 protease.
de Albuquerque CP; Suhandynata RT; Carlson CR; Yuan WT; Zhou H
J Biol Chem; 2018 Aug; 293(31):12105-12119. PubMed ID: 29903909
[TBL] [Abstract][Full Text] [Related]
18. The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing.
Haindl M; Harasim T; Eick D; Muller S
EMBO Rep; 2008 Mar; 9(3):273-9. PubMed ID: 18259216
[TBL] [Abstract][Full Text] [Related]
19. Wrestling with SUMO in a new arena.
Wilson VG; Rosas-Acosta G
Sci STKE; 2005 Jun; 2005(290):pe32. PubMed ID: 15985640
[TBL] [Abstract][Full Text] [Related]
20. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation.
Owerbach D; McKay EM; Yeh ET; Gabbay KH; Bohren KM
Biochem Biophys Res Commun; 2005 Nov; 337(2):517-20. PubMed ID: 16198310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
